Acitretin manufacturers and suppliers in india

Acitretin

Properties

Melting point:: 228-230°C

Boiling point:: 404.46°C (rough estimate)

Density: 1.1348 (rough estimate)

refractive index: 1.4700 (estimate)

storage temp.: -20°C

solubility: Practically insoluble in water, sparingly soluble in tetrahydrofuran, slightly soluble in acetone and in ethanol (96 per cent), very slightly soluble in cyclohexane.

form: powder

pka: 4.72±0.33(Predicted)

color: Light yellow to yellow

λmax: 352nm(MeOH)(lit.)

Merck: 14,112

Stability:: LIGHT SENSITIVE

Safety Information

Symbol(GHS): GHS07,GHS08,GHS09

Signal word: Danger

Hazard statements: H315-H319-H360-H410

Precautionary statements: P201-P273-P302+P352-P305+P351+P338-P308+P313

Hazard Codes: T,N

Risk Statements: 61-36/38-50/53

Safety Statements: 53-26-45-60-61-37/39

RIDADR: UN 3077 9/PG 3

WGK Germany: 3

RTECS: RA8460000

F: 8-10-21

HazardClass: 9

PackingGroup: III

HS Code: 2918992090

Toxicity: LD50 i.p. in mice (mg/kg): >4000 (1 day), 700 (10 days), 700 (20 days) (Bollag, 1978)

Use

Acitretin, a retinol derivative, was introduced in 1989 for the treatment of severe psoriasis. By the end of 1990, acitretin was confirmed to be metabolized in part to etretinate. Marketing authorization was suspended temporarily in France while the product information was modified to conform to the recommendations issued by the Committee for Proprietary Medicinal Products of the European Communities. Acitretin remains registered in several countries. See also WHO comment for etretinate.